Vaccinex (VCNX) Stock Chart & Stock Price History $0.46 -0.54 (-54.00%) As of 12:38 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaccinex Stock Price Performance The Vaccinex (VCNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 91.45%, with a year-to-date return of -53.06%. In the past month, the stock has decreased 35.21%, reflecting recent market activity. As of the latest close, Vaccinex traded at $1.00 with a market cap of $2.60 million and volume of 105 shares. Five years ago, the stock traded at a split-adjusted price of $1,083.60, representing a 99.96% decrease over that period. At the time, it had a market cap of $108.11 million and a volume of 863 shares. Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.53%1 Month Performance-35.21%3 Month Performance-32.39%Year-To-Date Performance-53.06%1 Year Performance-91.45%5 Year Performance-99.96% VCNX Stock Chart for Monday, August, 25, 2025 VCNX Chart by TradingView Vaccinex Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.52$1.00+93.95%$1.00$1.00105 shs$2.60 million08/21/2025$0.53$0.52-3.08%$0.52$0.52115 shs$1.34 million08/20/2025$0.42$0.53+26.04%$0.53$0.53247 shs$1.38 million08/19/2025$0.78$0.42-46.10%$0.42$0.42121 shs$1.10 million08/18/2025$0.78$0.78$1.11$0.775,025 shs$2.04 million08/15/2025$0.62$0.78+26.31%$1.11$0.775,025 shs$2.04 million08/14/2025$0.62$0.62-0.18%$0.62$0.62243 shs$1.61 million08/13/2025$0.70$0.62-11.37%$0.62$0.62104 shs$1.62 million08/12/2025$0.70$0.70$0.90$0.7018,603 shs$1.82 million08/11/2025$0.70$0.70+0.11%$0.90$0.7018,603 shs$1.82 million Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$0.71$0.70-1.41%$0.88$0.706,615 shs$1.82 million08/07/2025$0.75$0.71-5.33%$0.71$0.583,105 shs$1.85 million08/06/2025$0.88$0.75-14.76%$0.77$0.75534 shs$1.95 million08/05/2025$0.79$0.88+11.39%$0.88$0.753,618 shs$2.29 million08/04/2025$0.79$0.79$0.79$0.79305 shs$2.05 million08/01/2025$0.82$0.79-3.66%$0.79$0.79305 shs$2.05 million07/31/2025$0.80$0.82+2.49%$0.82$0.82136 shs$2.13 million07/30/2025$0.70$0.80+14.29%$0.80$0.80177 shs$2.08 million07/29/2025$0.88$0.70-20.40%$0.84$0.701,173 shs$1.82 million07/28/2025$0.71$0.88+23.86%$0.88$0.83979 shs$2.29 million07/25/2025$0.70$0.71+1.43%$0.77$0.712,774 shs$1.85 million07/24/2025$0.99$0.70-29.28%$0.98$0.70693 shs$1.82 million Related Companies CYCN Stock Chart ACXP Stock Chart PRTG Stock Chart RNAZ Stock Chart OBSV Stock Chart BMRA Stock Chart TRAW Stock Chart KZIA Stock Chart BCLI Stock Chart APM Stock Chart Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VCNX) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access